CHI’s Sixth Annual Microarrays in Medicine

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: May 04, 2005 End Date/Time: May 05, 2005
Report as Spam


The FDA’s anticipated Pharmacogenomic Guidance Document holds the promise that 2005 will be an extraordinary year for the advancement of the capabilities of microarrays.

Microarrays build bridges on which biologists and clinicians can meet to understand, diagnose, and treat diseases. The promises of microarrays are:
• rapid access to molecular pathways • a more precise diagnosis and prognosis of diseases
• a better understanding of drug action • the ability to better define therapeutic strategies

That, coupled with the FDA’s growing interest in the use of microarray-based genomic diagnostic devices, holds a bright future for both researchers developing pharmaceuticals and clinicians performing diagnostics. Optimizing “arrays” depends on carefully assessing your specific purposes. Cambridge Healthech Institute’s 6th Annual Microarrays in Medicine: Arrays of Possibilities, will provide practical information and results about new technical developments and specific applications to help determine which arrays are best for your specific application or research need.